Sunshine Biopharma Inc. (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals is pleased to ...

Aptevo Therapeutics ("Aptevo") today announced that Peter Pavlik, PhD, Senior Director of Protein Engineering, will chair a session titled "Bi and Multispecific Biologics" and present ...

This disrupted process results ... antibody-based drugs, offer some relief, they can be costly and not universally accessible. Alternative approaches, such as nucleic acid-based treatments ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.TRc4SPmX.js ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

NV ("etherna"), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announces a ...

RBD-7022 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Hyperlipidemia.

Aims to increase speed to market for drug developers working on nucleic acid therapeutics.

SynerK has novel nucleic acid drug technology platforms with independent intellectual property rights. Huadong Medicine will use its deep accumulation in innovative drug research and development and ...